Figure 3.
Effect of various doses of MEMC on the serum ALT, AST, and ALP (U/L) levels assessed against PCM-induced hepatic injury in rats. =Significantly different (P < 0.05) as compared to the ALT level in the normal control group. +Significantly different as compared to the AST level in the normal control group. *Significantly different as compared to the ALT level in the 10% DMSO + PCM-treated group. #Significantly different as compared to the AST level in the 10% DMSO + PCM-treated group. $Significantly different as compared to the ALP level in the 10% DMSO + PCM-treated group.